Results 171 to 180 of about 2,004,567 (296)

Majority of scholarly journals from India in WoS and SCOPUS are closed access and promoted by foreign publishers: A 2026 concern on technological embargo. [PDF]

Bioinformation
Bisht YS, Singh R, Pavithra S, Monisha S, Kameshwari M, Kamaleshwari M, Yogasri T, Nisha A, Vishnu Priya M, Viji A.   +9 more
europepmc   +1 more source

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

Molecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski, Júlia Perera‐Bel, Alejo Rodriguez‐Vida, Nuria Juanpere, Jihyun Lee, Daniel E. Michaud, Jennifer L. Guerriero, Kent W. Mouw, Aristotelis Bamias, Filipe L. F. Carvalho, Joaquim Bellmunt   +10 more
wiley   +1 more source

'Why is publishing so expensive?' [PDF]

Dis Model Mech
Brown K, Patton EE, Hackett R.
europepmc   +2 more sources

Acknowledgement to Reviewers (July 2017 - December 2018)

Clinical Management Issues, 2018
Laura Fascio Pecetto
doaj   +1 more source

Where do I submit my next paper? A practical guide for biomedical researchers. [PDF]

J Biomed Res
Alrashdan MS.
europepmc   +1 more source

CMI embraces Open Access philosophy

Clinical Management Issues, 2013
Laura Fascio Pecetto
doaj   +1 more source

Expanding equity horizons in knowledge sharing: How can global health journals level up? [PDF]

Int J Public Health
Bandara S, Sant Fruchtman C, Joubert N, Zinsstag L, Banerjee A, Beaulieu IM, Tetui M, Qiang V.   +7 more
europepmc   +1 more source

To publish or not to publish?

Annals of Tropical Medicine and Public Health, 2012
openaire   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Molecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych   +12 more
wiley   +1 more source

Research "junkification" is caused by researchers, not journals. [PDF]

Front Psychol
Groome SS, Yong JC, Li NP.
europepmc   +1 more source